Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Osimertinib
Tagrisso (osimertinib) received its first FDA approval on November 13, 2015. [1]
Yes. November 13, 2015 refers to the drug’s initial FDA approval (as opposed to later label expansions for additional stages or mutations). [1]
Later FDA approvals expanded Tagrisso’s indicated use to additional patient groups and settings beyond the original approval. Those expansions came after the first FDA approval date in 2015. [1] Sources: [1] https://www.drugs.com/history/tagrisso.html
Other Questions About Osimertinib :